Literature DB >> 32383417

25-year follow-up of treated and not-treated adolescents after the Spitak earthquake: course and predictors of PTSD and depression-ERRATUM.

Armen K Goenjian, Alan M Steinberg, David Walling, Sheryl Bishop, Ida Karayan, Robert Pynoos.   

Abstract

Entities:  

Keywords:  Depression; PTSD; disaster; earthquake; longitudinal study; risk and protective factors

Year:  2020        PMID: 32383417      PMCID: PMC8161427          DOI: 10.1017/S0033291720001348

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


× No keyword cloud information.
The above mentioned article was published in Psychological Medicine with some errors in Table 3. The correct version of Table 3 is shown below:
Table 3.

The full model and the final stepwise model for PTSD-RI, PCL, and CES-D scores at 25-year follow-up among adults who were early-adolescents in 1988

BβpBβp
Outcome variables and predictorsFinal model (best predictors)Full model
PTSD-RI score at 25 yearsF7, 127 = 9.98, p < 0.001, R2 = 0.36F13, 121 = 5.71, p < 0.001, R2 = 0.38
1. Home destruction−3.826−0.1460.055−3.867−0.1480.063
2. PTSD-RI at 1½ years0.2630.2120.0050.1990.1600.099
3. Treatment4.8980.2500.0325.1750.1740.027
4. Post-EQ adversities−8.128−0.2500.001−7.838−0.2410.001
5. Post-EQ chronic illnesses1.8770.2240.0032.2290.2660.001
6. Social support−0.415−0.265<0.001−0.382−0.2440.002
7. Sex3.6060.1380.0592.5930.0990.195
8. Nuclear family deaths−1.535−0.0850.259
9. Severe injuries due EQ−3.543−0.0960.225
10. Post-EQ trauma0.4110.0520.498
11. DSRS at 1½ years0.0250.0090.915
12. SAD. at 1½ years0.6110.1110.172
13. Education−1.689−0.0640.403
PCL score at 25 yearsF4, 130 = 15.78, p < 0.001, R2 = 0.33F13, 121 = 5.56, p < 0.001, R2 = 0.37
1. Home destruction−2.245−0.0750.345
2. PTSD-RI at 1½ years0.0960.0680.486
3. Treatment6.5420.1920.0095.1940.1530.053
4. Post-EQ adversities-5.186-0.1400.053−5.120−0.1380.064
5. Post-EQ chronic illnesses3.3960.354<0.0013.4820.364<0.001
6. Social support-0.526-0.294<0.001−0.501−0.280<0.001
7. Sex1.2940.0430.572
8. Nuclear family deaths−1.230−0.0590.430
9. Severe injuries due EQ−4.119−0.0980.220
10. Post-EQ trauma1.0040.1110.150
11. DSRS at 1½ years−0.115−0.0390.664
12. SAD at 1½ years0.6520.1040.205
13. Education−1.047−0.0350.651
CES-D score at 25 yearsF6, 128 = 14.08, p < 0.001, R2 = 0.40F13, 121 = 6.94, p < 0.001, R2 = 0.43
1. Home destruction−3.160−0.1310.065−2.537−0.1050.169
2. PTSD-RI at baseline0.1310.1140.222
3. Treatment3.2720.1190.114
4. Post-EQ adversities-6.785-0.2260.002−7.068−0.2350.001
5. Post-EQ chronic illnesses2.7980.362<0.0012.7980.362<0.001
6. Social support-0.420-0.290<0.001−0.428−0.296<0.001
7. Sex0.4670.0190.792
8. Nuclear family deaths1.3160.0790.276
9. Severe injuries due EQ−0.808−0.0240.755
10. Post-EQ trauma0.8800.1200.0930.7540.1030.162
11. DSRS at 1½ years0.0750.0310.715
12. SAD at 1½ years0.7910.1550.0260.9310.1830.020
13. Education−1.85−0.0760.302

PTSD-RI, Posttraumatic Stress Disorder-Reaction Index; PCL, PTSD Checklist; CES-D, Center for Epidemiologic Studies-Depression; EQ, earthquake; SAD, separation anxiety disorder. Reference groups used for the anayses: no home destruction; no treatment; no adversities; no death; and no injury.

The full model and the final stepwise model for PTSD-RI, PCL, and CES-D scores at 25-year follow-up among adults who were early-adolescents in 1988 PTSD-RI, Posttraumatic Stress Disorder-Reaction Index; PCL, PTSD Checklist; CES-D, Center for Epidemiologic Studies-Depression; EQ, earthquake; SAD, separation anxiety disorder. Reference groups used for the anayses: no home destruction; no treatment; no adversities; no death; and no injury. Cambridge University Press apologises for this error.
  1 in total

1.  25-year follow-up of treated and not-treated adolescents after the Spitak earthquake: course and predictors of PTSD and depression.

Authors:  Armen K Goenjian; Alan M Steinberg; David Walling; Sheryl Bishop; Ida Karayan; Robert Pynoos
Journal:  Psychol Med       Date:  2020-01-14       Impact factor: 7.723

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.